(non-transduced cells). A set of 53 downregulated genes pertaining to the, canonical, planar, Cell Growth & Profileration and Cell Migration, were identified. One of them, DAAM1, have been already described as direct targets of mir-335. Conclusions: Our results indicate a lower expression of mir335 in OAMSCs patients and suggest that the downregulation in Wnt related genes during the initial stages of differentiation that could be partly restored after mir335 overexpression. Therefore, we hypothesize that a diminished expression of mir335 could contribute to the altered function of MSCs in OA. Purpose: Several studies reported that an increase of subchondral bone area (tAB) is associated with features of radiographic knee osteoarthritis (rOA), such as osteophytes, joint space narrowing or subchondral defects. One cross-sectional study reported that tABs were larger in knees with higher KL grades, based on site readings from the OA initiative (OAI). Here we test the hypotheses that knees with rOA show greater rates of longitudinal tAB change than knees with risk factors but not definite radiographic OA (pre-rOA) or healthy knees without. Methods: Coronal FLASHwe MR images of 899 right knees from OAI participants (539 women, 360 men; age 61.6AE9.5; BMI 28.9AE4.8) were acquired at baseline and 12 month follow-up (public use datasets 0.E.1 and 1.E.1). Based on central radiographic readings (Boston University), 101 knees were classified asymptomatic healthy controls (bilateral KLG 0, no OA risk factors), 254 were pre-rOA (KLG 0&1, with risk factors), and 544 had definite rOA (KLG 2-4). The tAB of the medial and lateral tibia (MT/LT) and weight-bearing (central) femoral condyles (cMF/cLF) were segmented by experienced readers, by matching numbers of slices processed per plate in scan pairs, but with blinding to acquisition order. The size of the tAB was calculated in 3D. Because an increase in tAB was expected, 1-sided non-paired t-tests were used to compare groups, and significance of change was assessed with 1-sided paired t-tests. Results: tAB changes were less than 1% in all strata (Table 1) and were not significantly different from zero in healthy reference knees (SRM range -0.10 to +0.11). Pre-rOA knees had a significant (p<0.05) tAB increase in cMF (SRM +0.10) but not in other plates (SRM 0.05). rOA knees showed significant tAB increases in MT (SRM +0.14), cMF (SRM +0.21) and cLF (SRM +0.15), but not in LT (SRM +0.03). The changes were significantly greater than in rOA than in pre-rOA knees for MT and cLF (p< 0.05), and greater than in healthy controls for MT (p<0.05). In MT, the percent increase in tAB was greater in knees with higher KL grades. Conclusions: Knees with definite rOA show small but significant longitudinal increases in tAB, predominantly in the medial compartment. In the medial tibia, the rate of tAB change was greater in rOA than in pre-rOA or healthy knees. The observed relationship between tAB change and rOAI status in the medial tibia may be due to rOA predominantly affecting the medial compartment (in general and in the OAI) and because femorotibial loading is known to be greater medially than laterally. The current results suggest that longitudinal change in tABs is a feature of structural progression associated with rOA status.
Purpose: Several studies reported that an increase of subchondral bone area (tAB) is associated with features of radiographic knee osteoarthritis (rOA), such as osteophytes, joint space narrowing or subchondral defects. One cross-sectional study reported that tABs were larger in knees with higher KL grades, based on site readings from the OA initiative (OAI). Here we test the hypotheses that knees with rOA show greater rates of longitudinal tAB change than knees with risk factors but not definite radiographic OA (pre-rOA) or healthy knees without. Methods: Coronal FLASHwe MR images of 899 right knees from OAI participants (539 women, 360 men; age 61.6AE9.5; BMI 28.9AE4.8) were acquired at baseline and 12 month follow-up (public use datasets 0.E.1 and 1.E.1). Based on central radiographic readings (Boston University), 101 knees were classified asymptomatic healthy controls (bilateral KLG 0, no OA risk factors), 254 were pre-rOA (KLG 0&1, with risk factors), and 544 had definite rOA (KLG 2-4). The tAB of the medial and lateral tibia (MT/LT) and weight-bearing (central) femoral condyles (cMF/cLF) were segmented by experienced readers, by matching numbers of slices processed per plate in scan pairs, but with blinding to acquisition order. The size of the tAB was calculated in 3D. Because an increase in tAB was expected, 1-sided non-paired t-tests were used to compare groups, and significance of change was assessed with 1-sided paired t-tests. Results: tAB changes were less than 1% in all strata (Table 1) and were not significantly different from zero in healthy reference knees (SRM range -0.10 to +0.11). Pre-rOA knees had a significant (p<0.05) tAB increase in cMF (SRM +0.10) but not in other plates (SRM 0.05). rOA knees showed significant tAB increases in MT (SRM +0.14), cMF (SRM +0.21) and cLF (SRM +0.15), but not in LT (SRM +0.03). The changes were significantly greater than in rOA than in pre-rOA knees for MT and cLF (p< 0.05), and greater than in healthy controls for MT (p<0.05). In MT, the percent increase in tAB was greater in knees with higher KL grades. Conclusions: Knees with definite rOA show small but significant longitudinal increases in tAB, predominantly in the medial compartment. In the medial tibia, the rate of tAB change was greater in rOA than in pre-rOA or healthy knees. The observed relationship between tAB change and rOAI status in the medial tibia may be due to rOA predominantly affecting the medial compartment (in general and in the OAI) and because femorotibial loading is known to be greater medially than laterally. The current results suggest that longitudinal change in tABs is a feature of structural progression associated with rOA status. (n¼36) were divided into 3 experimental groups (n¼12 per group). One group received reference diet (Control) whereas the other 2 groups received reference diet mixed with two different dosages of fenofibrate (100 mg/kg bodyweight (BW)/ day or 200 mg/kg BW/day). Mice were euthanized after 16 weeks of treatment at the age of 6 months. mCT was used to quantify subchondral bone volume (Sb.BV) in a pre-defined region of interest and subchondral plate thickness (Sb.Th), in addition to metaphyseal bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp). Level of inflammation was determined by measuring serum amyloid A (SAA). Knee cartilage damage was evaluated by histology using the OARSI scoring method. Results: Mice treated with 200 mg/kg BW/day fenofibrate had a significantly lower amount of subchondral bone, with lower Sb.BV and Sb.Th, as well as a lower amount of metaphyseal bone, with lower BV/TV and Tb.N and elevated Tb.Sp. No significant difference in cartilage damage was found between the groups. Fenofibrate treated mice had significantly lower levels of SAA compared to Control. Although no difference was found in SAA levels between mice with and without cartilage damage, reduced SAA was associated with less Sb.BV, BV/TV and Tb.Th. Conclusions: Systemic inflammation and subchondral bone volume and thickness in the STR/Ort mouse can be reduced by fenofibrate treatment. However, cartilage damage was not influenced. This suggests that PPARa signalling may influence subchondral bone morphology, but is not correlated with cartilage damage in the STR/Ort mouse. Acknowledgment: financial support of Top Institute Pharma (grant T1-213-1), Anna Fonds and Nuts Ohra 
